Search Within

Larry Norton

Formats
  1. Journal Article (410)
  2. Meeting Abstract (296)
  3. Book Section (21)
  4. Conference Paper (16)
  5. Editorial (8)
  6. Guidelines (3)
  7. Correspondence (2)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (760)
  2. Breast Medicine Service (760)
  3. Department of Medicine (760)
  4. Solid Tumor Oncology Division (760)
  5. Survivorship Research (393)
  6. GSK Faculty (224)

More Groups

People
  1. Clifford Hudis (293)
  2. Edi Brogi (115)
  3. Andrew Seidman (99)
  4. Sujata Patil (97)
  5. Mark Robson (90)
  6. Hannah Wen (83)

More People

Years
  1. 2025 (7)
  2. 2024 (19)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (13)
  6. 2020 (26)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (79)
  3. Breast Cancer Research and Treatment (48)
  4. Clinical Cancer Research (30)
  5. Laboratory Investigation (26)
  6. Modern Pathology (24)

More Publications

Publishers
  1. American Society of Clinical Oncology (160)
  2. American Association for Cancer Research (124)
  3. Nature Publishing Group (76)
  4. Springer (61)
  5. Oxford University Press (50)
  6. Elsevier Inc. (48)

More Publishers

Results (760)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multigene signatures for breast cancer management: Pandora's box or a jewelry box? A clinician's point of view
    Meeting Abstract

    Norton, L.
    International Journal of Biological Markers (2007)

    Fulltext@MSK | Save
  • Cardiac safety of adjuvant bevacizumab plus dose-dense doxorubicin/cyclophosphamide followed by nanoparticle albumin-bound paclitaxel in patients with early stage breast cancer
    Meeting Abstract

    Mcarthur, H. L.; Rugo, H.; Paulson, M.; Rourke, M.; Traina, T.; Panageas, K.; Steingart, R.; Dang, C.; Fornier, M.; Park, J.; more...
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save
  • Clinical, morphologic and immunophenotypic characteristics of primary breast carcinomas (BC) with brain metastases (BM)
    Meeting Abstract

    Brogi, E.; Murray, M. P.; Patil, S.; Akram, M.; Nehhozina, T.; Norton, L.; Seidman, A.; Tan, L. K.
    Modern Pathology (2007)

    Fulltext@MSK | Save
  • Clinical, morphologic and immunophenotypic characteristics of primary breast carcinomas (BC) with brain metastases (BM)
    Meeting Abstract

    Brogi, E.; Murray, M. P.; Patil, S.; Akram, M.; Nehhozina, T.; Norton, L.; Seidman, A.; Tan, L. K.
    Laboratory Investigation (2007)

    Fulltext@MSK | Save
  • Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B experience
    Journal Article

    Muss, H. B.; Berry, D. A.; Cirrincione, C.; Budman, D. R.; Henderson, I. C.; Citron, M. L.; Norton, L.; Winer, E. P.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    Journal Article

    Harris, L.; Fritsche, H.; Mennel, R.; Norton, L.; Ravdin, P.; Taube, S.; Somerfield, M. R.; Hayes, D. F.; Bast, R. C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17
    Journal Article

    Goss, P. E.; Ingle, J. N.; Martino, S.; Robert, N. J.; Muss, H. B.; Piccart, M. J.; Castiglione, M.; Tu, D. H.; Shepherd, L. E.; Pritchard, K. I.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Antibody and CD8+ T cell responses against HER2/neu required for tumor eradication after DNA immunization with a Flt-3 ligand fusion vaccine
    Journal Article

    Orlandi, F.; Venanzi, F. M.; Concetti, A.; Yamauchi, H.; Tiwari, S.; Norton, L.; Wolchok, J. D.; Houghton, A. N.; Gregor, P. D.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Developing targeted therapy - Discussion
    Journal Article

    Norton, L.
    Clinical Trials (2007)

    Fulltext@MSK | Save
  • Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I dose-escalation study
    Journal Article

    Modi, S.; Stopeck, A. T.; Gordon, M. S.; Mendelson, D.; Solit, D. B.; Bagatell, R.; Ma, W.; Wheler, J.; Rosen, N.; Norton, L.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save